CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 145 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.85 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $136,000 | +72.2% | 25,664 | -3.1% | 0.00% | +100.0% |
| Q3 2020 | $79,000 | +97.5% | 26,496 | +156.3% | 0.00% | – |
| Q2 2019 | $40,000 | -68.3% | 10,336 | -58.1% | 0.00% | -100.0% |
| Q1 2019 | $126,000 | +21.2% | 24,645 | -7.6% | 0.00% | -66.7% |
| Q4 2017 | $104,000 | +258.6% | 26,658 | +132.2% | 0.00% | 0.0% |
| Q3 2017 | $29,000 | +16.0% | 11,480 | -10.8% | 0.00% | -40.0% |
| Q1 2017 | $25,000 | +108.3% | 12,863 | +10.9% | 0.01% | +25.0% |
| Q4 2016 | $12,000 | – | 11,603 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 589,883 | $590,000 | 1.38% |
| Broadfin Capital, LLC | 8,200,000 | $8,610,000 | 0.96% |
| Avoro Capital Advisors LLC | 1,141,149 | $1,198,000 | 0.24% |
| CORRADO ADVISORS, LLC | 190,600 | $200,000 | 0.12% |
| Baker Brothers Advisors | 5,102,153 | $5,357,000 | 0.05% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 756,311 | $794,000 | 0.04% |
| Point72 Asset Management, L.P. | 2,272,816 | $2,386,000 | 0.02% |
| AGRAN LIBBIE | 44,000 | $46,000 | 0.01% |
| COMPTON CAPITAL MANAGEMENT INC /RI | 10,000 | $11,000 | 0.01% |
| KENNEDY CAPITAL MANAGEMENT LLC | 233,171 | $245,000 | 0.00% |